Healthcare -
Medical - Devices - NASDAQ - US
$ 1.64
2.5 %
$ 449 M
Market Cap
-1.12
P/E
Price Target
Average
82.93%
Revenue Forecast
Estimate
27.69%
EBIT
Estimate
4.21%
Net Income
Estimate
33.65%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Pacific Biosciences of California, Inc.
Wall Street analysts predict an average 1-year price target for PACB of $3 , with forecasts ranging from
a
low of
$2 to a high of $4 .
PACB Lowest Price Target
Wall Street Target
2 USD
21.95%
PACB Average Price Target
Wall Street Target
3 USD
82.93%
PACB Highest Price Target
Wall Street Target
4 USD
143.90%
REVENUE FORECAST
Revenue Forecast Chart PACB
EBIT FORECAST
EBIT Forecast Chart PACB
NET INCOME FORECAST
Net Income Chart PACB